Effects of platinum complexes on chymotrypsin

Area of Science:

• Biochemistry
• Enzymology
• Medicinal Chemistry

Background:

• Alpha-chymotrypsin is a key serine protease involved in various physiological processes.
• Platinum complexes are known for their therapeutic applications, particularly in cancer treatment.
• Understanding enzyme inhibition is crucial for drug development and biochemical research.

Purpose of the Study:

• To investigate the inhibitory potential of various platinum complexes against alpha-chymotrypsin.
• To compare the efficacy of different platinum compounds as enzyme inhibitors.
• To explore the effect of enzyme immobilization on platinum complex inhibition.

Main Methods:

• Enzyme inhibition assays were performed using a standard spectrophotometric method.
• Benzoyl-L-tyrosine ethyl ester served as the substrate for alpha-chymotrypsin.
• Different platinum complexes, including alkali metal, ammine, and ethylenediamine derivatives, were tested.

Main Results:

• Potassium tetrachloroplatinate (K2PtCl4) and rubidium tetrabromoplatinate (Rb2PtBr4) demonstrated significant alpha-chymotrypsin inhibition.
• Trans-diamminedichloroplatinum (trans-Pt(NH3)2Cl2) also showed effective inhibitory activity.
• Several other platinum complexes, including cis-diamminedichloroplatinum (cis-Pt(NH3)2Cl2), exhibited weak inhibitory effects.
• Notably, none of the tested platinum complexes inhibited an immobilized alpha-chymotrypsin preparation.

Conclusions:

• Specific platinum complexes possess potent inhibitory activity against soluble alpha-chymotrypsin.
• Enzyme immobilization significantly alters the susceptibility of alpha-chymotrypsin to inhibition by platinum complexes.
• These findings suggest potential differences in the interaction mechanisms between platinum complexes and soluble versus immobilized enzymes.